In:
SKIN The Journal of Cutaneous Medicine, National Society for Cutaneous Medicine, Vol. 4, No. 3 ( 2020-05-08), p. 268-
Abstract:
Eosinophilic annular erythema (EAE) is a rare eosinophilic dermatosis with few documented cases in the literature. It is considered either a distinct entity or subtype of Well’s syndrome (eosinophilic cellulitis), but EAE, in contrast to Well’s syndrome, is characterized by a chronic course and resistance to treatment. Therapies with reported efficacy include anti-malarial medications, suplatast tosilate, and dapsone. We report the first adult case of EAE to respond to dupilumab, an IL-4 receptor antagonist, which targets the type 2 inflammatory response associated with tissue eosinophilia.
Type of Medium:
Online Resource
ISSN:
2574-1624
DOI:
10.25251/skin.4.3.10
Language:
Unknown
Publisher:
National Society for Cutaneous Medicine
Publication Date:
2020
detail.hit.zdb_id:
3118037-1
Bookmarklink